Cell line development companies create and optimise cell lines for research, drug discovery and the manufacture of biological products. Their services support the production of recombinant proteins, antibodies, vaccines and advanced therapies.
This category includes companies working on:
Browse 62 UK cell line development companies below.
Precision-programmed human iPSC-derived cells for biomedical research
bit.bio is a Cambridge-based synthetic biology company that programmes human induced pluripotent stem cells into defined, mature cell types for use in pharmaceutical and academic research. Its precision cell programming technology produces consistent, characterised human cells at industrial scale, supporting drug…
Veterinary vaccine CDMO and aquaculture diagnostics for animal health
Marinnovac UK is a contract research and manufacturing organisation specialising in veterinary vaccine development and viral antigen production for animal and aquaculture health applications. The company holds the only VMD-approved viral autogenous vaccine manufacturing licence in the UK, offering services spanning…
CDMO and CRO for complex biologics and bioconjugate development
Abzena is an integrated CDMO and CRO specialising in complex biologics and bioconjugates, with cGMP facilities across the United States and a research presence in Cambridge, UK. Its services span antibody discovery, cell line development, bioconjugation and GMP manufacturing across monoclonal antibodies, antibody-drug…
Cell and gene therapy CDMO with clinical and commercial manufacturing
RoslinCT is a CDMO specialising in advanced cell and gene therapies. Operating purpose-built cGMP facilities at Edinburgh BioQuarter and in Hopkinton, Massachusetts, it provides process development, analytical testing, clinical and commercial manufacturing for autologous and allogeneic cell therapies, with particular…
Gene therapy and biologics CDMO with cGMP manufacturing in Liverpool
Pharmaron Biologics (UK) Ltd is a contract development and manufacturing organisation specialising in biologics and cell and gene therapy, operating from cGMP biomanufacturing facilities in Speke, Liverpool. The site offers end-to-end services spanning plasmid design, cell line development, viral vector process…
End-to-end production systems for cultivated meat
Cellcraft is a biotechnology company developing integrated systems for cultivated meat production. The company supplies the hardware, software, and biological inputs required to grow animal cells outside the body at commercial scale, targeting food producers and manufacturers seeking slaughter-free protein production.…
Patient-derived cell models and assays for oncology drug discovery
Dominion Biotech is a Cheshire-based biotechnology company developing patient-derived cell (PDC) models and assays to support oncology drug discovery and development. Working in partnership with cancer hospitals and academic collaborators, the company builds a diverse bank of PDC models reflecting the genetic…
Human iPSC models and AI phenomics for drug discovery
Pixl Bio combines human induced pluripotent stem cell (iPSC) models with AI-driven image analysis for drug discovery and safety research. Its portfolio includes liver cells, stellate cells and disease models, alongside CRISPR engineering, high-content Cell Painting and contract studies. These tools help researchers…
Cellular agriculture and biomanufacturing platforms for sustainable food production
Newform Foods is an industrial biotechnology company developing cell-based production platforms for sustainable food and functional ingredients. The company provides animal and plant cell-line development, culture-media optimisation, bioprocess engineering and scalable cultivation technologies. Its platform supports…
Microfluidic instruments for protein interaction and single-cell analysis
Fluidic Sciences is a company developing and supplying instruments for biopharmaceutical research, combining two complementary technology platforms. Its core offering covers in-solution protein interaction characterisation without immobilisation, alongside a high-throughput picodroplet platform for single-cell…
Engineered iPSC-derived exosomes for tissue-targeted drug delivery
Excellio Labs is a biotech developing engineered exosome platforms for targeted drug delivery. The technology exploits the inherent tissue-specificity of iPSC-derived extracellular vesicles, which are further surface-modified to create precision drug carriers capable of delivering nucleic acids, proteins, and small…
Engineered therapeutic red blood cells for rare metabolic and other diseases
Scarlet Therapeutics is a biotechnology company developing a platform for generating therapeutic red blood cells (tRBCs). Erythroid cell lines are genetically engineered to produce red blood cells carrying high concentrations of therapeutic proteins, exploiting their natural tissue distribution, 120-day circulating…
AI live cell imaging platform for stem cell therapy development
CellVoyant is a biotech developing AI-powered live cell imaging and process optimisation platforms for stem cell therapy development. The technology uses computer vision and neural network models to predict stem cell differentiation behaviour in real time, without destructive sampling, enabling earlier and more…
Stem cell platform for precision psychiatry and drug discovery
MeOmics Precision Medicine is a biotechnology company developing a precision psychiatry platform that combines genomics, phenomics, and stem cell-based cellular assays to generate biomarkers for severe mental illness. Patient-derived neurons, stimulated via multi-electrode array recording, produce electrophysiological…
Bioanalytical instruments and patient-derived organoid expansion services
Molecular Devices develops bioanalytical instruments, laboratory automation and cell-based research technologies for drug discovery. Its portfolio includes microplate readers, high-content imaging systems, clone screening instruments and laboratory analysis software. The company acquired Cardiff organoid specialist…
Global biologics CDMO for vaccines, antibodies, and advanced therapies
FUJIFILM Biotechnologies is a contract development and manufacturing organisation providing process development and cGMP manufacturing of biologics, vaccines, and cell and gene therapies. Its UK site at Billingham, Teesside, includes mammalian cell culture and microbial fermentation facilities, with the UK's largest…
Cell profiling and precision additives for biologic manufacturing
Silvia Bio is a University of Sheffield spin-out developing cell-profiling services and media additives for mammalian-cell biomanufacturing. Its platform identifies cellular bottlenecks limiting productivity and biologic product quality, then formulates bioreactor-compatible additives to address them without genetic…
Integrated bioprocessing platform for biologics development and manufacture
Biologic Technologies is a developer of intelligent bioprocessing platforms for biologics development and manufacturing. Its platform integrates complete biological workflows into a single automated device, combining precision fluid handling, in-line process analytics, and AI-driven optimisation. Application-specific…
Extracellular vesicle platform for consistent, scalable regenerative therapeutics
Mesenbio is a preclinical-stage biopharmaceutical company developing a cell line platform that produces a consistent, scalable supply of therapeutic extracellular vesicles, addressing a key bottleneck limiting this treatment class. The company's cells generate naturally bioactive vesicles with combined…
Pluripotent stem cell lines for cultivated meat production
Roslin Technologies is a biotech company developing and commercialising animal pluripotent stem cell lines for the cultivated meat industry. Its iPSC and ESC lines, covering beef, pork, lamb and seafood, are designed for scalable, indefinitely self-renewing production and can differentiate into muscle and fat tissue.…